Breaking News Instant updates and real-time market news.

13:55
09/15/20
09/15
13:55
09/15/20
13:55

Treasury Action: there was only a flicker of a bounce in Treasuries

Treasury Action: there was only a flicker of a bounce in Treasuries after the well received 20-year auction. But the gains on Wall Street and the demand for risk have left bonds under water. The 30-year bond is 2 bps cheaper on the day at 1.433%, while the 10-year is at 0.679%, and the 2-year is at 0.139%. The front end continues to outperform ahead of the FOMC where the market looks for further confirmation of its lower for a very long time stance.

TODAY'S FREE FLY STORIES

Earnings
Colgate-Palmolive reports Q3 adjusted EPS 79c, consensus 70c » 06:55
10/30/20
10/30
06:55
10/30/20
06:55
CL

Colgate-Palmolive

$76.71 /

-0.09 (-0.12%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

10/26/20 Truist
Colgate-Palmolive price target raised to $85 from $80 at Truist
07/22/20
Fly Intel: Top five analyst downgrades
07/22/20 Morgan Stanley
Colgate-Palmolive downgraded to Equal Weight on valuation at Morgan Stanley
07/22/20 Morgan Stanley
Colgate-Palmolive downgraded to Equal Weight from Overweight at Morgan Stanley
CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

CL Colgate-Palmolive
$76.71 /

-0.09 (-0.12%)

Recommendations
Callon Petroleum price target lowered to $6 from $9.75 at Citi » 06:55
10/30/20
10/30
06:55
10/30/20
06:55
CPE

Callon Petroleum

$5.09 /

+0.36 (+7.61%)

Citi analyst Brian Downey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPE Callon Petroleum
$5.09 /

+0.36 (+7.61%)

CPE Callon Petroleum
$5.09 /

+0.36 (+7.61%)

10/02/20 RBC Capital
Callon Petroleum price target lowered to $18 from $30 at RBC Capital
10/02/20 MKM Partners
Callon Petroleum price target lowered to $10 from $14 at MKM Partners
09/25/20
Fly Intel: Top five analyst initiations
09/25/20 Wells Fargo
Callon Petroleum initiated with an Underweight at Wells Fargo
CPE Callon Petroleum
$5.09 /

+0.36 (+7.61%)

CPE Callon Petroleum
$5.09 /

+0.36 (+7.61%)

CPE Callon Petroleum
$5.09 /

+0.36 (+7.61%)

Earnings
nVent Electric sees FY20 adjusted EPS $1.46-$1.51, consensus $1.44 » 06:54
10/30/20
10/30
06:54
10/30/20
06:54
NVT

nVent Electric

$17.96 /

+0.36 (+2.05%)

Sees FY20 reported sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVT nVent Electric
$17.96 /

+0.36 (+2.05%)

NVT nVent Electric
$17.96 /

+0.36 (+2.05%)

06/04/20 Rosenblatt
nVent Electric price target raised to $29 from $26 at Rosenblatt
02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/06/20 Barclays
nVent Electric upgraded to Overweight from Equal Weight at Barclays
NVT nVent Electric
$17.96 /

+0.36 (+2.05%)

Recommendations
Bio-Rad price target raised to $650 from $590 at Wells Fargo » 06:54
10/30/20
10/30
06:54
10/30/20
06:54
BIO

Bio-Rad

$568.15 /

+2.33 (+0.41%)

Wells Fargo analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

07/31/20 Wells Fargo
Bio-Rad price target raised to $590 from $525 at Wells Fargo
07/31/20 Citi
Bio-Rad price target raised to $625 from $525 at Citi
05/21/20 Wells Fargo
Bio-Rad price target raised to $525 from $495 at Wells Fargo
04/08/20 Jefferies
Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies
BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

Hot Stocks
Summit Midstream announces 1-for-15 reverse unit split » 06:53
10/30/20
10/30
06:53
10/30/20
06:53
SMLP

Summit Midstream

$0.73 /

-0.0196 (-2.61%)

Summit Midstream…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMLP Summit Midstream
$0.73 /

-0.0196 (-2.61%)

SMLP Summit Midstream
$0.73 /

-0.0196 (-2.61%)

01/07/20 Wells Fargo
Summit Midstream downgraded to Underweight at Wells Fargo
01/07/20 Wells Fargo
Summit Midstream downgraded to Underweight from Equal Weight at Wells Fargo
SMLP Summit Midstream
$0.73 /

-0.0196 (-2.61%)

SMLP Summit Midstream
$0.73 /

-0.0196 (-2.61%)

Upgrade
Marvell upgraded to Buy from Hold at Craig-Hallum » 06:53
10/30/20
10/30
06:53
10/30/20
06:53
MRVL

Marvell

$38.19 /

-1.35 (-3.41%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$38.19 /

-1.35 (-3.41%)

MRVL Marvell
$38.19 /

-1.35 (-3.41%)

10/20/20 KeyBanc
Marvell resumed with an Overweight at KeyBanc
10/13/20 Argus
Marvell showing accelerating momentum in 5G, says Argus
10/09/20 BMO Capital
Marvell price target raised to $42 from $32 at BMO Capital
10/09/20 Needham
Marvell price target raised to $47 from $39 at Needham
MRVL Marvell
$38.19 /

-1.35 (-3.41%)

MRVL Marvell
$38.19 /

-1.35 (-3.41%)

MRVL Marvell
$38.19 /

-1.35 (-3.41%)

MRVL Marvell
$38.19 /

-1.35 (-3.41%)

Recommendations
Alkermes risk/reward remains attractive after 'strong' Q3, says Mizuho » 06:52
10/30/20
10/30
06:52
10/30/20
06:52
ALKS

Alkermes

$16.25 /

+0.81 (+5.25%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$16.25 /

+0.81 (+5.25%)

ALKS Alkermes
$16.25 /

+0.81 (+5.25%)

10/15/20 Mizuho
Alkermes upgraded to Buy from Neutral at Mizuho
10/12/20 Cantor Fitzgerald
Alkermes shares should react positively to Adcom vote, says Cantor Fitzgerald
10/08/20 Mizuho
Alkermes briefing documents supportive of approval, says Mizuho
10/07/20 Evercore ISI
FDA briefing docs 'bode very well' for Alkermes, says Evercore ISI
ALKS Alkermes
$16.25 /

+0.81 (+5.25%)

ALKS Alkermes
$16.25 /

+0.81 (+5.25%)

Earnings
KKR reports Q3 EPS 48c, consensus 40c » 06:52
10/30/20
10/30
06:52
10/30/20
06:52
KKR

KKR

$34.78 /

+0.015 (+0.04%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

08/05/20 Citi
Citi adds KKR to U.S. Focus List, ups price target to $47.50
07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler
KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

KKR KKR
$34.78 /

+0.015 (+0.04%)

Earnings
nVent Electric reports Q3 adjusted EPS 45c, consensus 40c » 06:52
10/30/20
10/30
06:52
10/30/20
06:52
NVT

nVent Electric

$17.96 /

+0.36 (+2.05%)

Reports Q3 revenue $509M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVT nVent Electric
$17.96 /

+0.36 (+2.05%)

NVT nVent Electric
$17.96 /

+0.36 (+2.05%)

06/04/20 Rosenblatt
nVent Electric price target raised to $29 from $26 at Rosenblatt
02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/06/20 Barclays
nVent Electric upgraded to Overweight from Equal Weight at Barclays
NVT nVent Electric
$17.96 /

+0.36 (+2.05%)

Hot Stocks
Chevron reports Q3 net oil equivalent production down 7% » 06:51
10/30/20
10/30
06:51
10/30/20
06:51
CVX

Chevron

$68.86 /

+1.95 (+2.91%)

Chevron reports worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
10/20/20
Fly Intel: Top five analyst initiations
10/20/20 Credit Suisse
Chevron reinstated with an Outperform at Credit Suisse
10/14/20 HSBC
Chevron price target lowered to $86 from $93 at HSBC
CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

Hot Stocks
Eli Lilly, Incyte announce to present new baricitinib data » 06:51
10/30/20
10/30
06:51
10/30/20
06:51
LLY

Eli Lilly

$132.57 /

+1.27 (+0.97%)

, INCY

Incyte

$87.22 /

+0.12 (+0.14%)

Eli Lilly (LLY) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$132.57 /

+1.27 (+0.97%)

INCY Incyte
$87.22 /

+0.12 (+0.14%)

LLY Eli Lilly
$132.57 /

+1.27 (+0.97%)

10/27/20 Benchmark
Lilly stop may 'hint' at similar results for Regeneron cocktail, says Benchmark
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Eli Lilly initiated with a Buy at Truist
10/16/20 JPMorgan
Eli Lilly price target raised to $200 from $190 at JPMorgan
INCY Incyte
$87.22 /

+0.12 (+0.14%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
LLY Eli Lilly
$132.57 /

+1.27 (+0.97%)

INCY Incyte
$87.22 /

+0.12 (+0.14%)

LLY Eli Lilly
$132.57 /

+1.27 (+0.97%)

LLY Eli Lilly
$132.57 /

+1.27 (+0.97%)

LLY Eli Lilly
$132.57 /

+1.27 (+0.97%)

INCY Incyte
$87.22 /

+0.12 (+0.14%)

Recommendations
Twitter price target raised to $48 from $45 at Mizuho » 06:51
10/30/20
10/30
06:51
10/30/20
06:51
TWTR

Twitter

$52.46 /

+3.925 (+8.09%)

Mizuho analyst James Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$52.46 /

+3.925 (+8.09%)

TWTR Twitter
$52.46 /

+3.925 (+8.09%)

06:28 Today Barclays
Twitter price target raised to $36 from $30 at Barclays
06:04 Today Baird
Twitter shares could rebound if trends are sustainable, says Baird
04:52 Today Pivotal Research
Twitter earnings selloff brings 'fantastic entry point,' says Pivotal Research
10/27/20 BofA
Twitter price target raised to $58 from $52 at BofA
TWTR Twitter
$52.46 /

+3.925 (+8.09%)

TWTR Twitter
$52.46 /

+3.925 (+8.09%)

TWTR Twitter
$52.46 /

+3.925 (+8.09%)

TWTR Twitter
$52.46 /

+3.925 (+8.09%)

Earnings
ITT reports Q3 adjusted EPS 82c, consensus 71c » 06:49
10/30/20
10/30
06:49
10/30/20
06:49
ITT

ITT

$62.87 /

+2.04 (+3.35%)

Reports Q3 revenue $591M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITT ITT
$62.87 /

+2.04 (+3.35%)

ITT ITT
$62.87 /

+2.04 (+3.35%)

10/14/20 Oppenheimer
ITT price target raised to $72 from $66 at Oppenheimer
04/13/20 Stifel
ITT downgraded to Hold from Buy at Stifel
04/13/20 Stifel
ITT downgraded to Hold from Buy at Stifel
03/04/20 UBS
ITT upgraded to Buy from Neutral at UBS
ITT ITT
$62.87 /

+2.04 (+3.35%)

Hot Stocks
Novartis expands Kymriah manufacturing footprint with CAR-T site in Japan » 06:49
10/30/20
10/30
06:49
10/30/20
06:49
NVS

Novartis

$78.08 /

-0.25 (-0.32%)

Novartis announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$78.08 /

-0.25 (-0.32%)

NVS Novartis
$78.08 /

-0.25 (-0.32%)

10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
NVS Novartis
$78.08 /

-0.25 (-0.32%)

NVS Novartis
$78.08 /

-0.25 (-0.32%)

NVS Novartis
$78.08 /

-0.25 (-0.32%)

Hot Stocks
Chevron CEO says global demand continues to be impacted by pandemic » 06:49
10/30/20
10/30
06:49
10/30/20
06:49
CVX

Chevron

$68.86 /

+1.95 (+2.91%)

Chevron CEO Michael Wirth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
10/20/20
Fly Intel: Top five analyst initiations
10/20/20 Credit Suisse
Chevron reinstated with an Outperform at Credit Suisse
10/14/20 HSBC
Chevron price target lowered to $86 from $93 at HSBC
CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

Recommendations
Proofpoint price target lowered to $115 from $123 at Mizuho » 06:49
10/30/20
10/30
06:49
10/30/20
06:49
PFPT

Proofpoint

$103.00 /

-1.27 (-1.22%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

06:09 Today Piper Sandler
Proofpoint should be bought at current levels, says Piper Sandler
10/26/20 DA Davidson
Proofpoint price target lowered to $124 from $155 at DA Davidson
08/26/20 Wedbush
Proofpoint assumed with an Outperform at Wedbush
08/19/20
Fly Intel: Top five analyst upgrades
PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

Hot Stocks
Booz Allen sees FY21 cash from operating activities $600M-$650M  06:49
10/30/20
10/30
06:49
10/30/20
06:49
BAH

Booz Allen

$75.45 /

+0.81 (+1.09%)

 
ShowHide Related Items >><<
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

Earnings
Booz Allen raises FY21 adjusted EPS view to $3.60-$3.75 from $3.40-$3.60 » 06:48
10/30/20
10/30
06:48
10/30/20
06:48
BAH

Booz Allen

$75.45 /

+0.81 (+1.09%)

FY21 consensus $3.64.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

Earnings
Chevron reports Q3 adj. EPS 11c, consensus (27c) » 06:48
10/30/20
10/30
06:48
10/30/20
06:48
CVX

Chevron

$68.86 /

+1.95 (+2.91%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
10/20/20
Fly Intel: Top five analyst initiations
10/20/20 Credit Suisse
Chevron reinstated with an Outperform at Credit Suisse
10/14/20 HSBC
Chevron price target lowered to $86 from $93 at HSBC
CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

CVX Chevron
$68.86 /

+1.95 (+2.91%)

Recommendations
Novocure price target raised to $150 from $84 at Mizuho » 06:47
10/30/20
10/30
06:47
10/30/20
06:47
NVCR

Novocure

$123.27 /

+7.72 (+6.68%)

Mizuho analyst Difei Yang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$123.27 /

+7.72 (+6.68%)

NVCR Novocure
$123.27 /

+7.72 (+6.68%)

10/29/20 Piper Sandler
Novocure price target raised to $140 from $125 at Piper Sandler
10/05/20 Piper Sandler
Bristol-Myers approval removes some Novocure revenue upside, says Piper Sandler
09/23/20
Fly Intel: Top five analyst initiations
09/23/20 Northland
Novocure initiated with an Outperform at Northland
NVCR Novocure
$123.27 /

+7.72 (+6.68%)

Hot Stocks
Booz Allen reports total backlog up 7.3% y/y to $24.6B  06:46
10/30/20
10/30
06:46
10/30/20
06:46
BAH

Booz Allen

$75.45 /

+0.81 (+1.09%)

 
ShowHide Related Items >><<
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

Recommendations
LivePerson price target raised to $75 from $65 at Mizuho » 06:46
10/30/20
10/30
06:46
10/30/20
06:46
LPSN

LivePerson

$57.04 /

+0.08 (+0.14%)

Mizuho analyst Siti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPSN LivePerson
$57.04 /

+0.08 (+0.14%)

LPSN LivePerson
$57.04 /

+0.08 (+0.14%)

10/23/20 B. Riley Securities
LivePerson price target raised to $66 from $63 at B. Riley Securities
10/02/20 Northland
Twilio comments positive for Kaleyra, LivePerson and Vonage, says Northland
08/05/20 B. Riley FBR
LivePerson price target raised to $63 from $49 at B. Riley FBR
08/05/20 Barclays
LivePerson price target raised to $64 from $49 at Barclays
LPSN LivePerson
$57.04 /

+0.08 (+0.14%)

LPSN LivePerson
$57.04 /

+0.08 (+0.14%)

LPSN LivePerson
$57.04 /

+0.08 (+0.14%)

Earnings
PNM Resources backs FY20 ongoing EPS view $2.23-$2.31, consensus $2.24 » 06:46
10/30/20
10/30
06:46
10/30/20
06:46
PNM

PNM Resources

$49.52 /

-0.04 (-0.08%)

Management affirmed its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNM PNM Resources
$49.52 /

-0.04 (-0.08%)

PNM PNM Resources
$49.52 /

-0.04 (-0.08%)

10/26/20 UBS
PNM Resources downgraded to Neutral from Buy at UBS
10/22/20 Barclays
PNM Resources downgraded to Equal Weight from Overweight at Barclays
10/22/20 Mizuho
PNM Resources downgraded to Neutral from Buy at Mizuho
10/21/20 Wells Fargo
PNM Resources downgraded to Equal Weight after Avangrid deal at Wells Fargo
PNM PNM Resources
$49.52 /

-0.04 (-0.08%)

  • 08
    Jan
Earnings
Booz Allen reports Q2 adjusted EPS $1.03, consensus 92c » 06:45
10/30/20
10/30
06:45
10/30/20
06:45
BAH

Booz Allen

$75.45 /

+0.81 (+1.09%)

Reports Q2 revenue $2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
08/03/20 Truist
Booz Allen downgraded to Hold from Buy at Truist
07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Raymond James
Booz Allen downgraded to Market Perform from Outperform at Raymond James
BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

BAH Booz Allen
$75.45 /

+0.81 (+1.09%)

Recommendations
Facebook price target raised to $350 from $330 at Mizuho » 06:45
10/30/20
10/30
06:45
10/30/20
06:45
FB

Facebook

$279.82 /

+12.12 (+4.53%)

Mizuho analyst James Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$279.82 /

+12.12 (+4.53%)

FB Facebook
$279.82 /

+12.12 (+4.53%)

06:27 Today Barclays
Facebook price target raised to $325 from $285 at Barclays
10/28/20 JPMorgan
Facebook price target raised to $315 from $300 at JPMorgan
10/26/20 KeyBanc
Facebook price target raised to $340 from $330 at KeyBanc
10/26/20 Mizuho
Facebook price target raised to $330 from $315 at Mizuho
FB Facebook
$279.82 /

+12.12 (+4.53%)

FB Facebook
$279.82 /

+12.12 (+4.53%)

FB Facebook
$279.82 /

+12.12 (+4.53%)

FB Facebook
$279.82 /

+12.12 (+4.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.